Sep 2012, Journal of Hepatology Editor's pick : 342,346 FibroTests worldwide to study fibrosis progression factors to cirrhosis
An overview of 3 studies including 494 patients with severe obesity (BMI>35kg/m2) showed a significant diagnostic value of non-invasive marker FibroMax for liver lesions with similar performances according to sex and diabetes.
BioPredictive is one of two industrial partners of the European consortium FLIP
Want to become a BioPredictive distributor?
You are a physician